GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinco Pharmaceutical Holdings Ltd (HKSE:06833) » Definitions » Days Payable

Sinco Pharmaceutical Holdings (HKSE:06833) Days Payable : 112.80 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Sinco Pharmaceutical Holdings Days Payable?

Sinco Pharmaceutical Holdings's average Accounts Payable for the six months ended in Dec. 2023 was HK$865 Mil. Sinco Pharmaceutical Holdings's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$1,399 Mil. Hence, Sinco Pharmaceutical Holdings's Days Payable for the six months ended in Dec. 2023 was 112.80.

The historical rank and industry rank for Sinco Pharmaceutical Holdings's Days Payable or its related term are showing as below:

HKSE:06833' s Days Payable Range Over the Past 10 Years
Min: 8.29   Med: 55.33   Max: 121.1
Current: 109.65

During the past 10 years, Sinco Pharmaceutical Holdings's highest Days Payable was 121.10. The lowest was 8.29. And the median was 55.33.

HKSE:06833's Days Payable is ranked better than
70.97% of 93 companies
in the Medical Distribution industry
Industry Median: 72.99 vs HKSE:06833: 109.65

Sinco Pharmaceutical Holdings's Days Payable increased from Dec. 2022 (89.17) to Dec. 2023 (112.80). It may suggest that Sinco Pharmaceutical Holdings delayed paying its suppliers.


Sinco Pharmaceutical Holdings Days Payable Historical Data

The historical data trend for Sinco Pharmaceutical Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinco Pharmaceutical Holdings Days Payable Chart

Sinco Pharmaceutical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.15 100.95 121.10 80.94 105.64

Sinco Pharmaceutical Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.04 98.29 89.17 110.10 112.80

Competitive Comparison of Sinco Pharmaceutical Holdings's Days Payable

For the Medical Distribution subindustry, Sinco Pharmaceutical Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinco Pharmaceutical Holdings's Days Payable Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinco Pharmaceutical Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Sinco Pharmaceutical Holdings's Days Payable falls into.



Sinco Pharmaceutical Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Sinco Pharmaceutical Holdings's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (455.606 + 947.852) / 2 ) / 2424.67*365
=701.729 / 2424.67*365
=105.64

Sinco Pharmaceutical Holdings's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (781.768 + 947.852) / 2 ) / 1399.165*365 / 2
=864.81 / 1399.165*365 / 2
=112.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinco Pharmaceutical Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of Sinco Pharmaceutical Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinco Pharmaceutical Holdings (HKSE:06833) Business Description

Traded in Other Exchanges
N/A
Address
No. 1700, North Section of Tianfu Avenue, E5-1805, Global Centre, High-Tech Zone, Chengdu, Sichuan Province, Chengdu, CHN
Sinco Pharmaceutical Holdings Ltd is an investment holding company engaged in the provision of comprehensive marketing, promotion, and channel management service for imported pharmaceutical products and medical devices in China. The company has three operating segments; the sale of imported pharmaceutical products segment, the research and manufacturing of aesthetic medicine segment, and the medical beauty services segment. Its product offering includes Human albumin solutions and Antibiotics like Axetine and Medocef.
Executives
Huang Zhijian 2305 Beneficiary of a trust
Fullwealth Holdings Limited 2201 Interest of corporation controlled by you
Risun Investments Limited 2101 Beneficial owner
Wickhams Cay Trust Company Limited 2301 Trustee
Huang Xiangbin 2307 Founder of a discretionary trust who can infl

Sinco Pharmaceutical Holdings (HKSE:06833) Headlines

No Headlines